BIOGEN'S ALZHEIMER’S DRUG RECEIVES APPROVAL FROM US FDA

In a historic move, the U.S. Food and Drugs Administration (FDA) on Monday granted approval to Biogen Inc's Aducanumab, a drug which happens to be the first against the Alzheimer's disease.
This new drug Aducanumab, that was heavily criticised by a certain section of medical experts focuses to remove sticky deposits of a protein called amyloid beta from the brains of patients in earlier stages of Alzheimer's to stave off its....